Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Messina C, Giunta EF, Signori A, Rebuzzi SE, Banna GL, Maniam A, Buti S, Cattrini C, Fornarini G, Bauckneht M, Greystoke A, Plummer R, Oing C, Rescigno P. Messina C, et al. Among authors: giunta ef. Eur Urol Oncol. 2024 Apr;7(2):179-188. doi: 10.1016/j.euo.2023.07.013. Epub 2023 Aug 12. Eur Urol Oncol. 2024. PMID: 37574390 Free article. Review.
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.
Giunta EF, Caroli P, Scarpi E, Altavilla A, Rossetti V, Marini I, Celli M, Casadei C, Lolli C, Schepisi G, Bleve S, Brighi N, Cursano MC, Paganelli G, Matteucci F, De Giorgi U. Giunta EF, et al. Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):326-334. doi: 10.1007/s00259-024-06887-4. Epub 2024 Aug 29. Eur J Nucl Med Mol Imaging. 2024. PMID: 39207484 Free PMC article.
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Fornarini G, Rebuzzi SE, Buti S, Rescigno P, Merseburger A, Sternberg CN, de Giorgi U, Basso U, Maruzzo M, Giannatempo P, Ponzano M, Giunta EF, Catalano F, Murianni V, Damassi A, Cremante M, Gandini A, Puglisi S, Llaja Obispo MA, Signori A, Banna GL. Fornarini G, et al. Among authors: giunta ef. Minerva Urol Nephrol. 2023 Jun;75(3):308-318. doi: 10.23736/S2724-6051.22.05135-7. Epub 2022 Dec 13. Minerva Urol Nephrol. 2023. PMID: 36511379 Free article. Clinical Trial.
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact.
Gasperoni L, Giunta EF, Montanari D, Masini C, De Giorgi U. Gasperoni L, et al. Among authors: giunta ef. Expert Opin Drug Metab Toxicol. 2024 Jun;20(6):491-502. doi: 10.1080/17425255.2024.2353749. Epub 2024 May 22. Expert Opin Drug Metab Toxicol. 2024. PMID: 38778707 Free article. Review.
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network.
Banna GL, Basso U, Giunta EF, Fratino L, Rebuzzi SE, Buti S, Maruzzo M, De Giorgi U, Murianni V, Cinausero M, Lipari H, Gamba T, Caffo O, Bimbatti D, Dri A, Mosca A, Ermacora P, Vignani F, Msaki A, Bonifacio B, Lombardo V, Conteduca V, Fornarini G, Rescigno P. Banna GL, et al. Among authors: giunta ef. Curr Oncol. 2022 Oct 14;29(10):7745-7753. doi: 10.3390/curroncol29100612. Curr Oncol. 2022. PMID: 36290889 Free PMC article.
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant.
De Falco V, Natalicchio MI, Napolitano S, Coppola N, Conzo G, Martinelli E, Zanaletti N, Vitale P, Giunta EF, Vietri MT, Vitiello PP, Ciardiello D, Marinaccio A, De Vita F, Ciardiello F, Troiani T. De Falco V, et al. Among authors: giunta ef. Medicine (Baltimore). 2019 May;98(21):e15759. doi: 10.1097/MD.0000000000015759. Medicine (Baltimore). 2019. PMID: 31124962 Free PMC article.
61 results